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Research Briefing Nº 38 
 
A systematic rapid evidence assessment of late diagnosis 
 
This systematic rapid evidence assessment identifies the nature and extent of the literature on late 
diagnosis across a range of conditions. 
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The review was carried out by the Institute of 
Education’s Evidence for Policy and Practice 
Information and Co-ordinating Centre (EPPI-
Centre) in 2012. It was commissioned and funded 
by the Policy Research Programme in the 
Department of Health. 
 
 
Key findings 
 
Findings are of interest to policy makers, clinicians, general practitioners and patients. 
 
 Late diagnosis is of concern for those with chronic obstructive pulmonary disease (COPD), dementia, 
human immunodeficiency virus (HIV) and type 1 Diabetes. 
 COPD has a high prevalence of late diagnosis, with an estimated 80% of cases remaining 
undiagnosed. Many of these cases are patients in the milder stages of the disease. 
 Early dementia is hard to detect, with doctors acknowledging their difficulties in distinguishing between 
dementia and ‘normal ageing’. 
 The evidence suggests that a substantial proportion (16–51%) of children experience delayed diagnosis 
in type I diabetes. 
 Those engaging in high-risk behaviours were more likely to avoid HIV testing due to fear of a positive 
diagnosis, with worrying implications regarding onward transmission. Data from the Health Protection 
Agency indicates that 50% of new diagnoses are late in the UK. 
 Broadly, late diagnosis affects vulnerable groups such as older people or those living in poverty. 
 Patients delayed seeking help from clinicians for a number of conditions including chronic kidney 
disease, dementia, HIV, stroke, myocardial infarction, epilepsy and tuberculosis. Late presentation was 
linked to symptom misinterpretation and lack of knowledge. 
 Inadequate knowledge and training of doctors were barriers to prompt diagnosis for chronic kidney 
disease, COPD, dementia and tuberculosis. 
 Restricted access, insufficient consultation time and resource constraints hindered diagnosis. 
 There was very little material about the cost implications of delayed diagnosis. 
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What we did  
 
Delayed diagnosis results in serious 
consequences for patients and healthcare 
professionals and can incur substantial financial 
costs. While research focusing upon cancer 
suggests that late diagnosis leads to increased 
morbidity and mortality, the evidence for other 
conditions is less clear. This systematic rapid 
evidence assessment (SREA), an exhaustive 
overview and summary of existing high quality 
research evidence relevant to a research 
question, identifies the nature and extent of the 
literature on late diagnosis across a range of 
conditions. We wanted to know: 
 
 What is the prevalence of late diagnosis? 
 What are the determinants of late diagnosis? 
 What are the outcomes of late diagnosis? 
 What are the cost implications of late 
diagnosis? 
 Which interventions reduce delays in 
diagnosis? 
 
How we did it 
 
We examined evidence from 43 systematic 
reviews for: chronic kidney disease, dementia, 
depression, type I diabetes, epilepsy, HIV, 
myocardial infarction, psychosis, stroke and 
tuberculosis. 
 
We found 606 UK primary studies on late 
diagnosis, of which 12 investigated COPD, 12 
investigated tuberculosis and 4 investigated 
epilepsy. While there were systematic reviews to 
draw on for most conditions, this was not the case 
for COPD (no systematic reviews), tuberculosis 
(systematic reviews with limited relevance to UK 
healthcare system) and epilepsy (systematic 
reviews focused on over-diagnosis), and so we 
used evidence from the primary studies. 
 
 
Implications 
 
The training of doctors in the early diagnosis of COPD, dementia and tuberculosis has improved detection. 
Media campaigns to alert the public to the symptoms of stroke, heart attack and psychosis have had mixed 
results. Overall, public recognition has increased, but this may not have contributed to shortening patient 
delay. 
 
This study includes information from health care systems outside the UK. However, policy makers may find 
future reviews of UK primary research into the late diagnosis of these conditions useful to understand the 
nature of the problem in a UK context.  
 
Further information 
 
For the full report see ‘A systematic rapid evidence assessment of late diagnosis’   
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